2016 annual financial data
Eloxx Pharmaceuticals 2016 Revenue growth
Direct answer
Revenue growth was 0%.
Operating income was -3,714,032 USD and net income was -8,267,929 USD.
Operating cash flow was -3,676,215 USD.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 75,000 USD
- Operating income
- -3,714,032 USD
- Net income
- -8,267,929 USD
- Operating cash flow
- -3,676,215 USD